CORC  > 湖南中医药大学
Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives
He, Ni-Ya; Li, Qing; Wu, Chun-Yan; Ren, Zhong; Gao, Ya; Pan, Li-Hong; Wang, Mei-Mei; Wen, Hong-Yan(文红艳); Jiang, Zhi-Sheng; Tang, Zhi-Han*
刊名Acta Pharmacologica Sinica
2017
卷号38期号:3页码:301-311
关键词PCSK9 LDL receptor monoclonal antibodies anti-sense oligonucleotide mimetic peptides adnectin CRISPR/Cas9 platform berberine oleanollc acid neuronal apoptosis coronary artery disease cholesterol metabolism
ISSN号1671-4083
DOI10.1038/aps.2016.134
URL标识查看原文
WOS记录号WOS:000395792800001;PMID:28112180
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5706665
专题湖南中医药大学
作者单位1.[Gao, Ya
2.Jiang, Zhi-Sheng
3.Ren, Zhong
4.Li, Qing
5.Tang, Zhi-Han
6.Tang, ZH
7.Liu, Lu-Shan
8.He, Ni-Ya
9.Wang, Mei-Mei
10.Wu, Chun-Yan
推荐引用方式
GB/T 7714
He, Ni-Ya,Li, Qing,Wu, Chun-Yan,et al. Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives[J]. Acta Pharmacologica Sinica,2017,38(3):301-311.
APA He, Ni-Ya.,Li, Qing.,Wu, Chun-Yan.,Ren, Zhong.,Gao, Ya.,...&Liu, Lu-Shan*.(2017).Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives.Acta Pharmacologica Sinica,38(3),301-311.
MLA He, Ni-Ya,et al."Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives".Acta Pharmacologica Sinica 38.3(2017):301-311.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace